Search by Drug Name or NDC

    NDC 73473-0309-30 Tazarotene 0.5 mg/g Details

    Tazarotene 0.5 mg/g

    Tazarotene is a CUTANEOUS GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Solaris Pharma Corporation. The primary component is TAZAROTENE.

    Product Information

    NDC 73473-0309
    Product ID 73473-309_aa11ee21-0fa2-4a1a-a1cb-d171cf71e649
    Associated GPIs
    GCN Sequence Number 031600
    GCN Sequence Number Description tazarotene GEL (GRAM) 0.05 % TOPICAL
    HIC3 L5F
    HIC3 Description ANTIPSORIATICS AGENTS
    GCN 29221
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Generic
    Proprietary Name Tazarotene
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route CUTANEOUS
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Solaris Pharma Corporation
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213644
    Listing Certified Through 2024-12-31

    Package

    NDC 73473-0309-30 (73473030930)

    NDC Package Code 73473-309-30
    Billing NDC 73473030930
    Package 1 TUBE in 1 CARTON (73473-309-30) / 30 g in 1 TUBE
    Marketing Start Date 2023-08-01
    NDC Exclude Flag N
    Pricing Information N/A